SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-084892
Filing Date
2021-03-18
Accepted
2021-03-18 07:06:02
Documents
13
Period of Report
2021-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d115698d8k.htm   iXBRL 8-K 25026
2 EX-99.1 d115698dex991.htm EX-99.1 56985
  Complete submission text file 0001193125-21-084892.txt   221975

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avro-20210318.xsd EX-101.SCH 3066
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20210318_lab.xml EX-101.LAB 19656
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20210318_pre.xml EX-101.PRE 12312
6 EXTRACTED XBRL INSTANCE DOCUMENT d115698d8k_htm.xml XML 3593
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 21753066
SIC: 2836 Biological Products, (No Diagnostic Substances)